Suri Charu, Awasthi Amit, Asthana Shailendra
Translational Health Science and Technology Institute (THSTI), Haryana 121001, India.
Translational Health Science and Technology Institute (THSTI), Haryana 121001, India.
Drug Discov Today. 2022 Feb;27(2):652-663. doi: 10.1016/j.drudis.2021.11.022. Epub 2021 Nov 24.
ROR-γt, the master regulator of Th-17 cells, is activated by the binding of small molecules at its orthosteric site, followed by the recruitment of co-activators or co-repressors in the ligand binding domain (LBD). Th-17 cells provide immune-dependent protection against cancers and pathogens. Their dysregulation causes inflammation and is therefore implicated in various autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and psoriasis. Consequently, there is enormous interest in the development of ROR-γt modulators, both agonist and inverse-agonists. Here, we review advances in the development of ROR-γt modulators that have been made over the past decade, focusing on the rich crystallography landscape for ROR-γt co-crystals that has delineated the relationship between the binding patterns of modulators and the resulting biological activities.
ROR-γt是Th-17细胞的主要调节因子,小分子在其正构位点结合可激活该因子,随后在配体结合域(LBD)募集共激活因子或共抑制因子。Th-17细胞提供针对癌症和病原体的免疫依赖性保护。它们的失调会引发炎症,因此与多种自身免疫性疾病有关,如多发性硬化症、类风湿性关节炎和牛皮癣。因此,人们对开发ROR-γt调节剂(激动剂和反向激动剂)有着浓厚的兴趣。在此,我们综述了过去十年中ROR-γt调节剂开发方面的进展,重点关注ROR-γt共晶体丰富的晶体学研究情况,这些研究描绘了调节剂的结合模式与所产生的生物学活性之间的关系。